Artificial intelligence is rapidly transforming drug discovery, clinical development, data science, investment, and the broader life sciences ecosystem. But for leaders working at the forefront of the industry, the most important question is no longer simply what AI can do. How do we turn the promise of AI into meaningful, measurable progress in biopharma? It will require better questions, stronger collaboration, clearer strategies, and meaningful dialogue between the people building the future of biopharma.
The @Philly AI in Biopharma Executive Summit brings together a carefully curated community of senior leaders, decision-makers, researchers, investors, and practitioners for a focused conversation about the future of AI-enabled biopharma.
A Different Kind of Industry Gathering
The @Philly AI in Biopharma Executive Summit is designed to be more than another industry conference.
We are creating a focused environment where experienced professionals can exchange perspectives, challenge assumptions, share real-world experiences, and explore where AI can create meaningful value across the biopharma ecosystem.
100–150 Carefully Selected Participants
A deliberately curated audience of senior leaders and professionals across:
Pharmaceutical & Biotechnology
Drug Discovery • R&D • Translational Medicine • Clinical Development
AI & Technology
AI/ML • Generative AI • Computational Biology • Data Science
Business & Strategy
Corporate Strategy • Business Development • Partnerships • Innovation
Investment
Venture Capital • Private Equity • Corporate Venture • Life Sciences Investment
Academia & Research
Biomedical AI • Computational Biology • Translational Research
Discussion Over Promotion
This is intentionally not a traditional large-scale conference.
The summit is designed around peer-to-peer exchange rather than product pitches or passive presentations.
Our goal is to create the kind of substantive conversation that is difficult to achieve at a large industry conference.
Participants will have the opportunity to:
- Exchange perspectives with experienced leaders across AI and biopharma
- Hear what is actually happening in the field beyond the headlines and hype
- Challenge conventional assumptions about where AI is creating value
- Discuss real-world opportunities and barriers
- Connect with peers facing similar scientific, strategic, and organizational questions
- Explore potential collaborations, partnerships, and investment opportunities
Built for people who are building, deciding, and investing.
Featured Keynote Speaker
Featured Speakers
We are bringing together leaders and experienced practitioners from across the biopharma, AI, academic, and investment communities. Each speaker brings direct experience in the areas shaping the future of AI-enabled biopharma.
Confirmed speakers include (and the list is growing):
Dimitris Agrafiotis, Ph.D.
Director, Digital, Analytics, and AI, Arsenal Capital Partners
Christos Davatzikos, PhD
Professor, University of Pennsylvania
Kevin He, M.B.A.
Director of Business Development
David Henderson, Ph.D.
Research Solutions Lead and Customer Engineer, Health Care and Life Sciences
Shivanjali Kumar, M.B.A., M.S., P.M.P.
Associate Director, Core Data Platform (Merck Research Laboratories)
Junshui Ma, Ph.D.
Associated VP
Li Shen, Ph.D., FAIMBE, FACMI, FAMIA
Professor, University of Pennsylvania
Jessica Striker, M.B.A., B.A.
Sr. Director, Clinical Operations
Fei Wang, Ph.D.
Professor. Population Health Sciences.
Long Wang, MD, PhD
SVP, Head of Regulatory, Mineralys Therapeutics
Huafeng Xu, Ph.D.
Chief Executive Officer, Fathom Therapeutics
Lixia Yao, Ph.D.
CEO & Founder
What You Will Take Away
Perspective
Gain insight into how experienced industry leaders are thinking about the opportunities and limitations of AI in biopharma.
Connections
Build relationships with senior professionals, decision-makers, investors, researchers, and technology leaders.
Real-World Insights
Move beyond AI hype and explore what is actually working—and where significant challenges remain.
New Opportunities
Identify potential technologies, partnerships, investment opportunities, and ideas that could influence your organization’s next steps.
Who Should Attend?
The summit is designed for professionals with a direct role in shaping the future of AI and biopharma.
Pharmaceutical & Biotechnology Leaders
R&D • Drug Discovery • Translational Medicine • Clinical Development • Data Science • AI/ML
Corporate & Business Leaders
Strategy • Business Development • Partnerships • Innovation
AI & Technology Leaders
Artificial Intelligence • Machine Learning • Generative AI • Computational Biology • Data Platforms
Investors
Venture Capital • Private Equity • Corporate Venture • Life Sciences Investment
Academic & Research Leaders
Biomedical AI • Computational Biology • Translational Research • Drug Discovery